| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.22B | +9.0% |
| Cost of Revenue | $2.03B | +15.7% |
| Gross Profit | $4.20B | +6.0% |
| R&D Expense | $879.0M | +31.0% |
| SG&A Expense | $1.74B | +18.6% |
| Operating Income | $1.58B | -13.4% |
| Pre-tax Income | $1.61B | -15.0% |
| Income Tax | $262.4M | +61.8% |
| Net Income | $1.32B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.58B | +22.5% |
| Short-term Investments | $2.54B | -12.9% |
| Accounts Receivable | $942.1M | +20.4% |
| Inventory | $893.2M | +52.1% |
| Current Assets | $6.25B | +7.0% |
| Total Assets | $12.97B | -4.3% |
| Current Liabilities | $1.42B | +23.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.49B | -28.6% |
| Investing Cash Flow | $1.37B | +155.7% |
| Financing Cash Flow | -$2.57B | -6082.1% |
| -22.4% |
| EPS (Basic) | $3.72 | -22.3% |
| EPS (Diluted) | $3.65 | -21.7% |
| Total Liabilities |
| $1.86B |
| +16.1% |
| Stockholders' Equity | $11.04B | -7.2% |